Cargando…

TIMP-1 and CD82, a promising combined evaluation marker for PDAC

Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1–tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well under...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiexin, Wu, Tijun, Zhan, Shanshan, Qiao, Nan, Zhang, Xu, Zhu, Yunxia, Yang, Nan, Sun, Yujie, Zhang, Xin A, Bleich, David, Han, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351648/
https://www.ncbi.nlm.nih.gov/pubmed/28030805
http://dx.doi.org/10.18632/oncotarget.14133
_version_ 1782514802382340096
author Zhang, Jiexin
Wu, Tijun
Zhan, Shanshan
Qiao, Nan
Zhang, Xu
Zhu, Yunxia
Yang, Nan
Sun, Yujie
Zhang, Xin A
Bleich, David
Han, Xiao
author_facet Zhang, Jiexin
Wu, Tijun
Zhan, Shanshan
Qiao, Nan
Zhang, Xu
Zhu, Yunxia
Yang, Nan
Sun, Yujie
Zhang, Xin A
Bleich, David
Han, Xiao
author_sort Zhang, Jiexin
collection PubMed
description Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1–tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well understood. In this study, we identify tetraspanin CD82 (also called KAI1) as a component of the promiscuous TIMP-1 interacting protein complex on cell surface of human pancreatic adenocarcinoma cells. CD82 directly binds to TIMP-1 N-terminal region through its large extracellular loop and co-localizes with TIMP-1 in both cancer cell lines and clinical samples. Moreover, CD82 facilitates membrane-bound TIMP-1 endocytosis, which significantly contributes to the anti-migration effect of TIMP-1. CD82 silencing partially eliminates these functions. TIMP-1 and CD82 expression status in patients with pancreatic ductal adenocarcinoma (PDAC) might demonstrate future usefulness as a differentiation marker and give us new insight into tumorigenic metastatic potential.
format Online
Article
Text
id pubmed-5351648
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53516482017-04-13 TIMP-1 and CD82, a promising combined evaluation marker for PDAC Zhang, Jiexin Wu, Tijun Zhan, Shanshan Qiao, Nan Zhang, Xu Zhu, Yunxia Yang, Nan Sun, Yujie Zhang, Xin A Bleich, David Han, Xiao Oncotarget Research Paper Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a widely secreted protein that regulates cell motility, proliferation, and apoptosis. Although it is recognized that TIMP-1–tetraspanin CD63 regulates epithelial cell apoptosis and proliferation, how TIMP-1 controls cell motility is not well understood. In this study, we identify tetraspanin CD82 (also called KAI1) as a component of the promiscuous TIMP-1 interacting protein complex on cell surface of human pancreatic adenocarcinoma cells. CD82 directly binds to TIMP-1 N-terminal region through its large extracellular loop and co-localizes with TIMP-1 in both cancer cell lines and clinical samples. Moreover, CD82 facilitates membrane-bound TIMP-1 endocytosis, which significantly contributes to the anti-migration effect of TIMP-1. CD82 silencing partially eliminates these functions. TIMP-1 and CD82 expression status in patients with pancreatic ductal adenocarcinoma (PDAC) might demonstrate future usefulness as a differentiation marker and give us new insight into tumorigenic metastatic potential. Impact Journals LLC 2016-12-24 /pmc/articles/PMC5351648/ /pubmed/28030805 http://dx.doi.org/10.18632/oncotarget.14133 Text en Copyright: © 2017 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Zhang, Jiexin
Wu, Tijun
Zhan, Shanshan
Qiao, Nan
Zhang, Xu
Zhu, Yunxia
Yang, Nan
Sun, Yujie
Zhang, Xin A
Bleich, David
Han, Xiao
TIMP-1 and CD82, a promising combined evaluation marker for PDAC
title TIMP-1 and CD82, a promising combined evaluation marker for PDAC
title_full TIMP-1 and CD82, a promising combined evaluation marker for PDAC
title_fullStr TIMP-1 and CD82, a promising combined evaluation marker for PDAC
title_full_unstemmed TIMP-1 and CD82, a promising combined evaluation marker for PDAC
title_short TIMP-1 and CD82, a promising combined evaluation marker for PDAC
title_sort timp-1 and cd82, a promising combined evaluation marker for pdac
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351648/
https://www.ncbi.nlm.nih.gov/pubmed/28030805
http://dx.doi.org/10.18632/oncotarget.14133
work_keys_str_mv AT zhangjiexin timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT wutijun timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT zhanshanshan timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT qiaonan timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT zhangxu timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT zhuyunxia timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT yangnan timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT sunyujie timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT zhangxina timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT bleichdavid timp1andcd82apromisingcombinedevaluationmarkerforpdac
AT hanxiao timp1andcd82apromisingcombinedevaluationmarkerforpdac